Corient Private Wealth
TMDX icon

Corient Private Wealth’s Transmedics TMDX Stock Holding History

Corient Private Wealth’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.28M Buy
19,285
+10,644
+123% +$901K ﹤0.01% 1653
2026
Q1 		$858K Buy
8,641
+5,557
+180% +$725K ﹤0.01% 1739
2025
Q4 		$375K Buy
3,084
+757
+33% +$95K ﹤0.01% 2028
2025
Q3 		$261K Buy
2,327
+36
+2% +$4.21K ﹤0.01% 2204
2025
Q2 		$307K Buy
+2,291
New +$252K ﹤0.01% 1977
2024
Q4 		– Sell
-1,463
Closed -$230K – 2537
2024
Q3 		$230K Sell
1,463
-500
-25% -$77K ﹤0.01% 2158
2024
Q2 		$296K Buy
+1,963
New +$235K ﹤0.01% 1930

Other funds holding TMDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Corient Private Wealth's TMDX Position: Q2 2026 in Review

Corient Private Wealth increased its Transmedics (TMDX) stake by 123% in Q2 2026, buying an estimated $901K and bringing the position to 19,285 shares worth $1.28M. The position accounts for ﹤0.01% of the portfolio, ranked #1653.

Corient Private Wealth first reported a position in TMDX in Q2 2024 and has held it in 7 quarters since. 374 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

  • Corient Private Wealth held 19,285 shares of Transmedics worth $1.28M as of Q2 2026.
  • Corient Private Wealth bought 10,644 Transmedics shares in Q2 2026, an estimated $901K.
  • Transmedics made up ﹤0.01% of Corient Private Wealth's portfolio in Q2 2026, its #1653 holding.
  • Corient Private Wealth first reported a position in Transmedics in Q2 2024 and has held it in 7 quarters since.
  • 374 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on Corient Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.